What Can We Learn from Animal Models to Study Schizophrenia?

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Schizophrenia is a complex neurodevelopmental disorder with positive, negative, and cognitive symptoms.
• Its exact cause is unknown but involves neurodevelopmental issues and neurotransmitter dysregulation (dopamine, glutamate, GABA).
• Animal models are vital for studying disease mechanisms and developing new treatments.

Purpose of the Study:

• To review existing rodent models for schizophrenia research.
• To highlight the strengths and weaknesses of various models.
• To discuss the potential of proteomics in schizophrenia research.

Main Methods:

• Pharmacological models using drug-induced effects.
• Models based on neurodevelopmental disruption.
• Models involving demyelination and genetic alterations.
• Application of proteomic technologies.

Main Results:

• Various rodent models offer insights into schizophrenia's multifaceted nature.
• Each model type presents unique advantages and limitations for translational research.
• Proteomics can elucidate molecular pathways in schizophrenia.

Conclusions:

• Rodent models are indispensable tools for advancing schizophrenia research.
• A combination of model systems and advanced technologies like proteomics is key.
• Further research using these models promises novel therapeutic strategies for schizophrenia.